Title: Interferon-Mediated Control of Neuropathogenic Flaviviruses Abstract: The primary research goals of this Mentored Clinical Scientist Research Career Development Award proposal are to study mechanisms by which antiviral interferons suppress neuropathogenic Flaviviruses. Flaviviruses, including Zika virus (ZIKV) and West Nile virus (WNV), can cause severe neurological complications, including brain disruption sequence and encephalitis. These manifestations are the net result of both virus-induced effects and host immune responses. The type I interferon (IFN) response establishes a cellular antiviral state through the induction of hundreds of IFN-stimulated genes (ISGs), many of which have direct antiviral effects. Through a cell-based screen to identify novel antiviral ISGs, the candidate uncovered C19orf66 as a potent inhibitor of multiple RNA viruses, including WNV, ZIKV, and Venezuelan equine encephalitis virus (VEEV). The candidate has shown that C19orf66 is required for an optimal IFN response and targets the viral life cycle at the stage of genome replication. Additionally, C19orf66 is basally expressed in primary human neural progenitor cells (hNPs), a useful model to study Zika virus-host interaction. Here, the candidate proposes to further characterize the mechanism of C19orf66 inhibition of Flaviviruses. A combination of molecular virological, cell biological, and biochemical approaches will be used to study: 1) the precise viral life cycle step inhibited by C19orf66, 2) the contribution of C19orf66 to antiviral immunity in hNP cell culture models and 3) the in vivo relevance in a mouse model of ZIKV infection. This research plan, complemented by a comprehensive career development plan that capitalizes on the candidate?s strong clinical interest in central nervous system infections, will lead to an independent research career laid on the foundation of strong education and sound technical skills. The research component of this award will be conducted in the laboratory of Dr. John Schoggins at UT Southwestern, who has significant expertise in basic virology and innate immunity, with additional oversight by co-mentor, Dr. Beth Levine, an expert in virus-host interactions with a strong history of successful mentorship. Critical to the candidate?s career development are attendance and presentations at professional conferences, regular meetings with her advisory committee, courses in fundamentals of neuroscience and immunology, mentorship and career development, research ethics, and hands-on training in the neuroscience lab of Dr. Genevieve Konopka. In summary, this training plan will satisfy the candidate?s short-term goals to strengthen her neuroscience and immunology fund of knowledge and expand her experience in basic science, providing for her long-term goal of independent research in the innate immune control of neuropathogenic Flaviviruses.

Public Health Relevance

Mosquito-borne viruses such as West Nile and Zika can lead to devastating infections of the brain of adults and developing fetuses. The front-line of the immune system fight against such viruses are proteins that inhibit the life cycle of these viruses. We have identified an uncharacterized protein that inhibits West Nile and Zika virus, and this study will characterize the functions of this protein and the defenses of such vulnerable cells as developing neurons and its role in a mouse model of Zika virus infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Clinical Investigator Award (CIA) (K08)
Project #
1K08AI132751-01A1
Application #
9744298
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Woodson, Sara Elaine
Project Start
2019-02-12
Project End
2024-01-31
Budget Start
2019-02-12
Budget End
2020-01-31
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Pediatrics
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390